{"id":2602,"date":"2024-11-26T02:07:47","date_gmt":"2024-11-25T22:37:47","guid":{"rendered":"http:\/\/uro-med.ir\/kidney-cancer\/?page_id=2602"},"modified":"2025-05-16T09:51:22","modified_gmt":"2025-05-16T06:21:22","slug":"advance-and-metastatic-rcc","status":"publish","type":"page","link":"https:\/\/uro-med.ir\/kidney-cancer\/advance-and-metastatic-rcc\/","title":{"rendered":"advance and metastatic Rcc"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t
<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\"\"\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
<\/path><\/svg><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
    \n
  1. \u062a\u0631\u06a9\u06cc\u0628 Lenvatinib\u2013pembrolizumab<\/strong> \u200f(I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632 ESMO-MCBS: \u06f4)\u060c Axitinib\u2013pembrolizumab<\/strong> \u00a0\u200f(I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632: \u06f4) \u06cc\u0627 Cabozantinib\u2013nivolumab<\/strong> \u200f (I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632: \u06f1) \u0628\u0631\u0627\u06cc \u062f\u0631\u0645\u0627\u0646 \u062e\u0637 \u0627\u0648\u0644 ccRCC \u067e\u06cc\u0634\u0631\u0641\u062a\u0647 \u062a\u0648\u0635\u06cc\u0647 \u0645\u06cc\u200c\u0634\u0648\u062f\u060c \u0635\u0631\u0641\u200c\u0646\u0638\u0631 \u0627\u0632 \u06af\u0631\u0648\u0647 \u062e\u0637\u0631 \u062f\u0631 \u0637\u0628\u0642\u0647\u200c\u0628\u0646\u062f\u06cc <\/strong>IMDC<\/strong>.<\/li>\n
  2. \u0647\u06cc\u0686 \u062a\u0631\u06a9\u06cc\u0628 \u062a\u0631\u062c\u06cc\u062d\u06cc<\/strong> \u0645\u06cc\u0627\u0646 \u0645\u0647\u0627\u0631\u06a9\u0646\u0646\u062f\u0647 PD-1 \u0648 TKI\u0647\u0627\u06cc \u0636\u062f VEGFR \u0648\u062c\u0648\u062f \u0646\u062f\u0627\u0631\u062f \u0648 \u0645\u0642\u0627\u06cc\u0633\u0647\u200c\u0647\u0627\u06cc \u063a\u06cc\u0631\u0645\u0633\u062a\u0642\u06cc\u0645 \u0645\u06cc\u0627\u0646 \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u0645\u062e\u062a\u0644\u0641 \u062a\u0648\u0635\u06cc\u0647 \u0646\u0645\u06cc\u200c\u0634\u0648\u062f<\/strong>.<\/li>\n
  3. \u062a\u0631\u06a9\u06cc\u0628 Ipilimumab\u2013nivolumab<\/strong> \u0628\u0631\u0627\u06cc \u0628\u06cc\u0645\u0627\u0631\u0627\u0646 \u0628\u0627 \u0631\u06cc\u0633\u06a9 \u0645\u062a\u0648\u0633\u0637 \u06cc\u0627 \u0628\u0627\u0644\u0627 \u0628\u0631 \u0627\u0633\u0627\u0633 <\/strong>IMDC<\/strong> \u00a0\u062a\u0648\u0635\u06cc\u0647 \u0645\u06cc\u200c\u0634\u0648\u062f (I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632 ESMO-MCBS:4) \u0648 \u0645\u06cc\u200c\u062a\u0648\u0627\u0646\u062f \u0628\u0647\u200c\u0639\u0646\u0648\u0627\u0646 \u06cc\u06a9 \u06af\u0632\u06cc\u0646\u0647 \u062f\u0631 \u0628\u06cc\u0645\u0627\u0631\u0627\u0646 \u0628\u0627 \u0631\u06cc\u0633\u06a9 \u0645\u0637\u0644\u0648\u0628 (<\/strong>favourable-risk<\/strong>)<\/strong> \u0646\u06cc\u0632 \u0645\u0637\u0631\u062d \u0634\u0648\u062f \u200f(I, C).<\/li>\n
  4. \u062a\u0631\u06a9\u06cc\u0628 Axitinib\u2013toripalimab<\/strong> \u0645\u06cc\u200c\u062a\u0648\u0627\u0646\u062f \u062f\u0631 \u0628\u06cc\u0645\u0627\u0631\u0627\u0646 \u0628\u0627 \u0631\u06cc\u0633\u06a9 \u0645\u062a\u0648\u0633\u0637 \u06cc\u0627 \u0628\u0627\u0644\u0627<\/strong> \u0628\u0647\u200c\u06a9\u0627\u0631 \u0631\u0648\u062f \u200f(I, C)\u061b \u0628\u0627 \u0627\u06cc\u0646 \u062d\u0627\u0644\u060c \u0627\u06cc\u0646 \u062a\u0631\u06a9\u06cc\u0628 \u0647\u0646\u0648\u0632 \u062a\u0623\u06cc\u06cc\u062f\u06cc\u0647 <\/strong>FDA<\/strong> \u00a0<\/strong>\u06cc\u0627 <\/strong>EMA<\/strong> \u00a0<\/strong>\u0631\u0627 \u062f\u0631\u06cc\u0627\u0641\u062a \u0646\u06a9\u0631\u062f\u0647 \u0627\u0633\u062a<\/strong>.<\/li>\n
  5. \u062f\u0627\u0631\u0648\u0647\u0627\u06cc Sunitinib<\/strong> \u200f[I, C]\u060c Pazopanib<\/strong> \u200f [I, C] \u00a0\u0648 Tivozanib<\/strong> \u200f[II, C] \u00a0\u0645\u06cc\u200c\u062a\u0648\u0627\u0646\u0646\u062f \u0628\u0647\u200c\u0639\u0646\u0648\u0627\u0646 \u062c\u0627\u06cc\u06af\u0632\u06cc\u0646\u200c\u0647\u0627\u06cc \u0628\u0627\u0644\u0642\u0648\u0647<\/strong> \u0628\u0631\u0627\u06cc \u062a\u0631\u06a9\u06cc\u0628\u0627\u062a \u0645\u0628\u062a\u0646\u06cc \u0628\u0631 PD-1 \u062f\u0631 \u0628\u06cc\u0645\u0627\u0631\u0627\u0646 \u0628\u0627 \u0631\u06cc\u0633\u06a9 \u0645\u0637\u0644\u0648\u0628 \u0628\u0631 \u0627\u0633\u0627\u0633 <\/strong>IMDC<\/strong> \u0627\u0633\u062a\u0641\u0627\u062f\u0647 \u0634\u0648\u0646\u062f\u060c \u0632\u06cc\u0631\u0627 \u0634\u0648\u0627\u0647\u062f \u0631\u0648\u0634\u0646\u06cc \u0627\u0632 \u0628\u0631\u062a\u0631\u06cc \u062a\u0631\u06a9\u06cc\u0628\u0627\u062a <\/strong>PD-1 <\/strong>\u0646\u0633\u0628\u062a \u0628\u0647 <\/strong>Sunitinib<\/strong> \u062f\u0631 \u0627\u06cc\u0646 \u06af\u0631\u0648\u0647 \u0648\u062c\u0648\u062f \u0646\u062f\u0627\u0631\u062f<\/strong>.<\/li>\n
  6. \u00a0<\/li>\n<\/ol>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t<\/div>\n\n\t\n\t\t\t\t\t\t
    \n\n\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
    <\/path><\/svg><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
    \n\t\t\t\t\t\t

    \u00a0<\/p>\n

      \n
    • \n
        \n
      • \u062f\u0627\u0631\u0648\u0647\u0627\u06cc Sunitinib<\/strong> \u200f[I, A]\u060c Pazopanib<\/strong> \u00a0\u200f[I, A] \u00a0\u0648Tivozanib<\/strong> \u200f[II, B] \u0628\u0647\u200c\u0639\u0646\u0648\u0627\u0646 \u062c\u0627\u06cc\u06af\u0632\u06cc\u0646\u200c\u0647\u0627\u06cc \u062a\u0631\u06a9\u06cc\u0628\u0627\u062a \u0645\u0628\u062a\u0646\u06cc \u0628\u0631 \u0645\u0647\u0627\u0631\u06a9\u0646\u0646\u062f\u0647\u200c\u0647\u0627\u06cc PD-1 \u062f\u0631 \u062f\u0631\u0645\u0627\u0646 \u062e\u0637 \u0627\u0648\u0644 \u0645\u0637\u0631\u062d \u0647\u0633\u062a\u0646\u062f\u060c \u0628\u0647\u200c\u0648\u06cc\u0698\u0647 \u0632\u0645\u0627\u0646\u06cc \u06a9\u0647 \u062f\u0631\u0645\u0627\u0646 \u0628\u0627 ICI\u0647\u0627 \u06a9\u0646\u062a\u0631\u0627\u0627\u0646\u062f\u06cc\u06a9\u0627\u0633\u06cc\u0648\u0646 \u062f\u0627\u0631\u062f \u06cc\u0627 \u062f\u0631 \u062f\u0633\u062a\u0631\u0633 \u0646\u06cc\u0633\u062a<\/strong>.<\/li>\n
      • \u062f\u0627\u0631\u0648\u06cc Cabozantinib<\/strong> \u0646\u06cc\u0632 \u062f\u0631 \u0628\u06cc\u0645\u0627\u0631\u0627\u0646 \u0628\u0627 \u0631\u06cc\u0633\u06a9 \u0645\u062a\u0648\u0633\u0637 \u06cc\u0627 \u0628\u0627\u0644\u0627 \u0628\u0631 \u0627\u0633\u0627\u0633 \u0637\u0628\u0642\u0647\u200c\u0628\u0646\u062f\u06cc<\/strong>IMDC<\/strong> \u06a9\u0647 \u0646\u0645\u06cc\u200c\u062a\u0648\u0627\u0646\u0646\u062f \u062f\u0631\u0645\u0627\u0646 \u0645\u0628\u062a\u0646\u06cc \u0628\u0631 PD-1 \u062f\u0631\u06cc\u0627\u0641\u062a \u06a9\u0646\u0646\u062f\u060c \u06af\u0632\u06cc\u0646\u0647\u200c\u0627\u06cc \u0645\u0646\u0627\u0633\u0628 \u0645\u062d\u0633\u0648\u0628 \u0645\u06cc\u200c\u0634\u0648\u062f \u200f(II, A).<\/li>\n
      • \u062a\u0631\u06a9\u06cc\u0628Axitinib\u2013avelumab<\/strong> \u0645\u0632\u06cc\u062a\u06cc \u062f\u0631 \u0628\u0642\u0627\u06cc \u06a9\u0644\u06cc (OS) \u0646\u0633\u0628\u062a \u0628\u0647 Sunitinib \u0646\u0634\u0627\u0646 \u0646\u062f\u0627\u062f\u0647 \u0627\u0633\u062a \u0648 \u0628\u0646\u0627\u0628\u0631\u0627\u06cc\u0646 \u0646\u0633\u0628\u062a \u0628\u0647 \u062f\u0631\u0645\u0627\u0646 \u0628\u0627 <\/strong>TKI<\/strong> \u062a\u06a9\u200c\u062f\u0627\u0631\u0648\u06cc\u06cc \u0628\u0631\u062a\u0631\u06cc \u0646\u062f\u0627\u0631\u062f \u0648 \u062a\u0648\u0635\u06cc\u0647 \u0646\u0645\u06cc\u200c\u0634\u0648\u062f<\/strong> \u200f[I, D\u061b \u0627\u0645\u062a\u06cc\u0627\u0632 ESMO-MCBS : \u06f3].<\/li>\n
      • \u067e\u0627\u06cc\u0634 \u0641\u0639\u0627\u0644 (<\/strong>surveillance<\/strong>)<\/strong> \u0645\u06cc\u200c\u062a\u0648\u0627\u0646\u062f \u062f\u0631 \u062a\u062d\u062a\u200c\u0645\u062c\u0645\u0648\u0639\u0647\u200c\u06cc \u06a9\u0648\u0686\u06a9\u06cc \u0627\u0632 \u0628\u06cc\u0645\u0627\u0631\u0627\u0646 \u0628\u0627 \u0631\u06cc\u0633\u06a9 \u0645\u0637\u0644\u0648\u0628<\/strong> \u06a9\u0647 \u062f\u0642\u06cc\u0642\u0627\u064b \u062a\u0639\u0631\u06cc\u0641 \u0646\u0634\u062f\u0647\u200c\u0627\u0646\u062f\u060c \u06af\u0632\u06cc\u0646\u0647\u200c\u06cc \u062c\u0627\u06cc\u06af\u0632\u06cc\u0646 \u0628\u0627\u0634\u062f (III, C). \u0627\u06cc\u0646 \u0631\u0648\u06cc\u06a9\u0631\u062f \u0646\u06cc\u0627\u0632\u0645\u0646\u062f \u0628\u0631\u0631\u0633\u06cc \u0648 \u0645\u0644\u0627\u062d\u0638\u0627\u062a \u062f\u0642\u06cc\u0642 \u0628\u0627\u0644\u06cc\u0646\u06cc \u0627\u0633\u062a.<\/li>\n
      • \u0642\u0637\u0639 \u062f\u0631\u0645\u0627\u0646 \u0628\u0627 \u0645\u0647\u0627\u0631\u06a9\u0646\u0646\u062f\u0647\u200c\u0647\u0627\u06cc \u0627\u06cc\u0645\u0646\u06cc (<\/strong>ICIs<\/strong>)<\/strong> \u067e\u0633 \u0627\u0632 \u06f2 \u0633\u0627\u0644 \u062f\u0631\u0645\u0627\u0646<\/strong> \u0628\u0627\u06cc\u062f \u0645\u0648\u0631\u062f \u062a\u0648\u062c\u0647 \u0642\u0631\u0627\u0631 \u06af\u06cc\u0631\u062f (IV, B).<\/li>\n
      • \u0648\u0642\u0641\u0647\u200c\u0647\u0627\u06cc \u062f\u0631\u0645\u0627\u0646\u06cc \u062f\u0631 \u0645\u0635\u0631\u0641 <\/strong>TKI<\/strong>\u0647\u0627\u06cc \u0636\u062f <\/strong>VEGFR<\/strong> \u0628\u0647 \u0646\u0638\u0631 \u0646\u0645\u06cc\u200c\u0631\u0633\u062f \u0627\u062b\u0631 \u0645\u0646\u0641\u06cc \u0628\u0631 \u0627\u062b\u0631\u0628\u062e\u0634\u06cc \u06a9\u0644\u06cc \u062f\u0631\u0645\u0627\u0646 \u062f\u0627\u0634\u062a\u0647 \u0628\u0627\u0634\u062f (I, C).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t<\/div>\n\n\t\n\t\t\t\t\t\t
        \n\n\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
        <\/path><\/svg><\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t
        \n\t\t\t\t\t\t
          \n
        • \u0627\u062f\u0627\u0645\u0647 \u062f\u0631\u0645\u0627\u0646 \u0628\u0627 \u0645\u0647\u0627\u0631\u06a9\u0646\u0646\u062f\u0647\u200c\u0647\u0627\u06cc<\/strong> VEGFR TKI <\/strong>\u067e\u0633 \u0627\u0632 \u062f\u0631\u0645\u0627\u0646 \u062e\u0637 \u0627\u0648\u0644 \u0628\u0627 \u062a\u0631\u06a9\u06cc\u0628\u0627\u062a \u0647\u062f\u0641\u0645\u0646\u062f \u0639\u0644\u06cc\u0647<\/strong> PD-1<\/strong>\u060c \u0627\u0633\u062a\u0627\u0646\u062f\u0627\u0631\u062f \u0645\u0631\u0627\u0642\u0628\u062a\u06cc \u0645\u062d\u0633\u0648\u0628 \u0645\u06cc\u200c\u0634\u0648\u062f \u200f[I, B].<\/li>\n
        • \u0628\u0627\u06cc\u062f \u0627\u0632 \u062f\u0627\u0631\u0648\u0647\u0627\u06cc \u0636\u062f<\/strong> VEGFR<\/strong> \u06a9\u0647 \u0642\u0628\u0644\u0627\u064b \u0627\u0633\u062a\u0641\u0627\u062f\u0647 \u0646\u0634\u062f\u0647\u200c\u0627\u0646\u062f \u0628\u0647\u0631\u0647 \u06af\u0631\u0641\u062a \u200f[I, B].<\/li>\n
        • Cabozantinib<\/strong> \u062f\u0627\u0631\u0648\u06cc \u0627\u0631\u062c\u062d \u0628\u0631\u0627\u06cc \u062f\u0631\u0645\u0627\u0646 \u062e\u0637 \u062f\u0648\u0645 \u0627\u0633\u062a \u200f[II, B].<\/li>\n
        • \u0633\u0627\u06cc\u0631 \u06af\u0632\u06cc\u0646\u0647\u200c\u0647\u0627 \u0646\u06cc\u0632 \u0634\u0627\u0645\u0644 Axitinib<\/strong>\u060c Lenvatinib\u2013Everolimus<\/strong>\u060c Pazopanib<\/strong>\u060c Sunitinib<\/strong> \u0648 Tivozanib<\/strong> \u0647\u0633\u062a\u0646\u062f \u200f[III, B].<\/li>\n
        • \u062f\u0631 \u0628\u06cc\u0645\u0627\u0631\u0627\u0646\u06cc \u06a9\u0647 \u062f\u0631 \u062e\u0637 \u0627\u0648\u0644 \u062f\u0631\u0645\u0627\u0646 \u0628\u0627<\/strong> TKI <\/strong>\u0636\u062f<\/strong> VEGFR<\/strong> \u062f\u0631\u06cc\u0627\u0641\u062a \u06a9\u0631\u062f\u0647\u200c\u0627\u0646\u062f:<\/li>\n
        • Nivolumab<\/strong> (\u062f\u0631 \u0635\u0648\u0631\u062a \u062f\u0631 \u062f\u0633\u062a\u0631\u0633 \u0628\u0648\u062f\u0646 \u0648 \u0646\u0628\u0648\u062f \u06a9\u0646\u062a\u0631\u0627\u0627\u0646\u062f\u06cc\u06a9\u0627\u0633\u06cc\u0648\u0646) \u200f(I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632 ESMO-MCBS : \u06f5) \u0648 Cabozantinib<\/strong> \u200f[I, A] \u00a0\u0647\u0631 \u062f\u0648 \u0628\u0627\u0639\u062b \u0627\u0641\u0632\u0627\u06cc\u0634 \u0628\u0642\u0627\u06cc \u06a9\u0644\u06cc<\/strong> (OS)<\/strong> \u0645\u06cc\u200c\u0634\u0648\u0646\u062f.<\/li>\n
        • \u0633\u0627\u06cc\u0631 \u06af\u0632\u06cc\u0646\u0647\u200c\u0647\u0627\u06cc \u0642\u0627\u0628\u0644\u200c\u0627\u0633\u062a\u0641\u0627\u062f\u0647 \u0639\u0628\u0627\u0631\u062a\u200c\u0627\u0646\u062f \u0627\u0632: Axitinib<\/strong>\u060c Everolimus<\/strong> \u0648 Lenvatinib\u2013Everolimus<\/strong> \u200f[II, B].<\/li>\n
        • Belzutifan<\/strong> \u0646\u06cc\u0632 \u06af\u0632\u06cc\u0646\u0647\u200c\u06cc \u062c\u0627\u06cc\u06af\u0632\u06cc\u0646 \u0628\u0631\u0627\u06cc \u0628\u06cc\u0645\u0627\u0631\u0627\u0646\u06cc \u0627\u0633\u062a \u06a9\u0647 \u067e\u0633 \u0627\u0632 \u062f\u0631\u06cc\u0627\u0641\u062a \u062f\u0631\u0645\u0627\u0646 \u062a\u0631\u06a9\u06cc\u0628\u06cc \u0636\u062f<\/strong> VEGFR\u2013PD-1<\/strong> \u00a0\u062f\u0686\u0627\u0631 \u067e\u06cc\u0634\u0631\u0641\u062a \u0628\u06cc\u0645\u0627\u0631\u06cc \u0634\u062f\u0647\u200c\u0627\u0646\u062f \u200f(III, B\u061b \u062f\u0627\u0631\u0627\u06cc \u062a\u0623\u06cc\u06cc\u062f\u06cc\u0647 FDA \u0648\u0644\u06cc \u0641\u0627\u0642\u062f \u062a\u0623\u06cc\u06cc\u062f\u06cc\u0647 EMA).<\/li>\n<\/ul>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t<\/div>\n\n\t\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
          \n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

          \u062a\u0631\u06a9\u06cc\u0628 Lenvatinib\u2013pembrolizumab \u200f(I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632 ESMO-MCBS: \u06f4)\u060c Axitinib\u2013pembrolizumab \u00a0\u200f(I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632: \u06f4) \u06cc\u0627 Cabozantinib\u2013nivolumab \u200f (I, A\u061b \u0627\u0645\u062a\u06cc\u0627\u0632: \u06f1) \u0628\u0631\u0627\u06cc \u062f\u0631\u0645\u0627\u0646 \u062e\u0637 \u0627\u0648\u0644 ccRCC \u067e\u06cc\u0634\u0631\u0641\u062a\u0647 \u062a\u0648\u0635\u06cc\u0647 \u0645\u06cc\u200c\u0634\u0648\u062f\u060c \u0635\u0631\u0641\u200c\u0646\u0638\u0631 \u0627\u0632 \u06af\u0631\u0648\u0647 \u062e\u0637\u0631 \u062f\u0631 \u0637\u0628\u0642\u0647\u200c\u0628\u0646\u062f\u06cc IMDC. \u0647\u06cc\u0686 \u062a\u0631\u06a9\u06cc\u0628 \u062a\u0631\u062c\u06cc\u062d\u06cc \u0645\u06cc\u0627\u0646 \u0645\u0647\u0627\u0631\u06a9\u0646\u0646\u062f\u0647 PD-1 \u0648 TKI\u0647\u0627\u06cc \u0636\u062f VEGFR \u0648\u062c\u0648\u062f \u0646\u062f\u0627\u0631\u062f \u0648 \u0645\u0642\u0627\u06cc\u0633\u0647\u200c\u0647\u0627\u06cc \u063a\u06cc\u0631\u0645\u0633\u062a\u0642\u06cc\u0645 \u0645\u06cc\u0627\u0646 \u0645\u0637\u0627\u0644\u0639\u0627\u062a \u0645\u062e\u062a\u0644\u0641 \u062a\u0648\u0635\u06cc\u0647 \u0646\u0645\u06cc\u200c\u0634\u0648\u062f. \u062a\u0631\u06a9\u06cc\u0628 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2602","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/pages\/2602","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/comments?post=2602"}],"version-history":[{"count":74,"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/pages\/2602\/revisions"}],"predecessor-version":[{"id":4347,"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/pages\/2602\/revisions\/4347"}],"wp:attachment":[{"href":"https:\/\/uro-med.ir\/kidney-cancer\/wp-json\/wp\/v2\/media?parent=2602"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}